Canopy Growth (CGC) Equity Average (2018 - 2025)
Canopy Growth's (CGC) quarterly Equity Average came in at $539.2 million in Q4 2025, up 35.31% year-on-year from $398.5 million in Q4 2024, and up 21.49% quarter-over-quarter from $443.9 million in Q3 2025.
Canopy Growth (CGC) Equity Average (2018 - 2025) Analysis & Trends
Canopy Growth has disclosed Equity Average across 8 years of filings, most recently posting $539.2 million for Q4 2025.
- Equity Average for Q4 2025 came in at $539.2 million, up 35.31% year-over-year; the trailing twelve-month figure through Dec 2025 was $539.2 million (up 35.31% YoY), and the FY2025 annual result was $355.5 million, down 23.85% from the prior year.
- Equity Average came in at $539.2 million for Q4 2025 at Canopy Growth, up from $443.9 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $3.4 billion in Q3 2021 to a low of $346.2 million in Q2 2025.
- The 5-year median for Equity Average is $595.8 million (2023), against an average of $1.3 billion.
- Across the five-year window, Equity Average sank 74.45% in 2023 and jumped 35.31% in 2025, its largest moves.
- Canopy Growth's Equity Average stood at $3.3 billion in 2021, then plunged by 67.07% to $1.1 billion in 2022, then plunged by 56.21% to $479.6 million in 2023, then declined by 16.9% to $398.5 million in 2024, then surged by 35.31% to $539.2 million in 2025.
- The last three Equity Average figures came in at $539.2 million (Q4 2025), $443.9 million (Q3 2025), and $346.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.15 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 493.55 Mn |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn | 539.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 539.24 Mn |
| Sep 30, 2025 | 443.86 Mn |
| Jun 30, 2025 | 346.22 Mn |
| Mar 31, 2025 | 381.48 Mn |
| Dec 31, 2024 | 398.51 Mn |
| Sep 30, 2024 | 381.63 Mn |
| Jun 30, 2024 | 380.54 Mn |
| Mar 31, 2024 | 385.75 Mn |
| Dec 31, 2023 | 479.56 Mn |
| Sep 30, 2023 | 594.99 Mn |
| Jun 30, 2023 | 596.56 Mn |
| Mar 31, 2023 | 781.18 Mn |
| Dec 31, 2022 | 1.10 Bn |
| Sep 30, 2022 | 1.24 Bn |
| Jun 30, 2022 | 2.06 Bn |
| Mar 31, 2022 | 3.06 Bn |
| Dec 31, 2021 | 3.33 Bn |
| Sep 30, 2021 | 3.37 Bn |
| Jun 30, 2021 | 3.06 Bn |
| Mar 31, 2021 | 2.98 Bn |